Holding(s) in Company | 14-Nov-2023 | 15:00 | RNS |
Capital Markets Day Events | 09-Nov-2023 | 07:00 | RNS |
New USA and Canada label claim for AivlosinÂ... | 24-Oct-2023 | 07:00 | RNS |
Result of AGM | 07-Sep-2023 | 14:57 | RNS |
Notice of AGM | 10-Aug-2023 | 07:00 | RNS |
Posting of the Annual Report and Accounts | 21-Jul-2023 | 16:25 | RNS |
Final Results for the Year Ended 31 March 2023 | 10-Jul-2023 | 07:00 | RNS |
Notice of Results & Investor Presentation | 05-Jul-2023 | 07:00 | RNS |
Issue of Equity and Total Voting Rights | 06-Jun-2023 | 07:00 | RNS |
Holding(s) in Company | 18-May-2023 | 07:00 | RNS |
Trading Update | 23-Mar-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 27-Feb-2023 | 10:37 | RNS |
Change of Registered Address | 24-Feb-2023 | 15:19 | RNS |
Holding(s) in Company | 17-Feb-2023 | 13:41 | RNS |
Holding(s) in Company | 13-Feb-2023 | 13:55 | RNS |
Currency | UK Pounds |
Share Price | 118.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 122.00 |
52 Week Low | 84.00 |
Volume | 88,184 |
Shares Issued | 67.74m |
Market Cap | £79.94m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 23-Sep-21 | 26-Sep-19 |
Paid | 22-Oct-21 | 16-Oct-19 |
Amount | 1.00p | 7.04p |
Time | Volume / Share Price |
12:56 | 40,000 @ 116.00p |
12:56 | 40,000 @ 116.08p |
15:19 | 2,500 @ 117.25p |
14:58 | 1,418 @ 116.00p |
11:14 | 44 @ 116.00p |
CFO | Christopher Wilks |
CEO | David Hallas |
You are here: research